Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Felodipine products are in shortage in Canada (1 of 6 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 7, 2026.
A calcium channel blocker used to treat high blood pressure.
Products affected
1 / 6
In shortage since
Feb 24, 2026
Est. full return
Aug 7, 2026
Reports on file
23
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
APO-FELODIPINE
5MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02452375 · since Jun 16, 2026, est. end Aug 7, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-FELODIPINE
5MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02452375 · since Feb 24, 2026, est. end May 15, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-FELODIPINE
10MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02452383 · ended Jan 30, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-FELODIPINE
5MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02452375 · ended Jan 23, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-FELODIPINE
5MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02452375 · ended Oct 10, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-FELODIPINE
10MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02452383 · ended Oct 10, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-FELODIPINE
2.5MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02452367 · ended Feb 8, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-FELODIPINE
10MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02452383 · ended Feb 8, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-FELODIPINE
5MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02452375 · ended Feb 1, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-FELODIPINE
10MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02452383 · ended Jul 28, 2023 · Disruption of the manufacture of the drug.
Resolved
APO-FELODIPINE
5MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02452375 · ended Jul 28, 2023 · Disruption of the manufacture of the drug.
Resolved
APO-FELODIPINE
2.5MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02452367 · ended Jul 28, 2023 · Disruption of the manufacture of the drug.
Showing 12 of 23 reports. All reports are on file with Health Canada.
What's happening
Felodipine is currently affected by an active shortage report filed with Health Canada by APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Felodipine is classified under “SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.” (ATC C08CA).
Recent changes
Jul 9, 2026
Estimated end date moved earlier : Aug 28, 2026 → Aug 7, 2026
Common questions
What is Felodipine used for?
A calcium channel blocker used to treat high blood pressure.
When will Felodipine be back in stock in Canada?
The latest manufacturer estimate is Aug 7, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Felodipine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.